legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Health Insurance Fund (Tervisekassa) to Fund Chronic Migraine Treatment from Next Month

Health Insurance Fund (Tervisekassa) has announced plans to start funding chronic migraine treatment from the upcoming month, providing a new ray of hope for patients suffering from this debilitating condition. This decision comes after a long-awaited approval process, with the application for funding being submitted in 2020.

Getter Hark, the head of the medicines reimbursement service of the Health Insurance Fund, expressed his satisfaction with the agreement reached after years of negotiations with the marketing authorization holder. He stated that the drug will be included in the January list, marking a significant milestone for chronic migraine patients in Estonia. However, it is important to note that this newcomer drug will cost the health insurance budget Ôé¼200,000 annually.

With over 11,000 people diagnosed with chronic migraine this year, the drug is expected to bring relief and improve the quality of life for approximately 200 patients. Additionally, the accessibility of this treatment is expected to increase, as the drug will become more affordable in January. This, in turn, will likely lead to a rise in the number of users seeking this beneficial treatment.

This development has been met with enthusiasm from the medical community as well. Toomas Toomsoo, a neurologist, expressed his relief at being able to offer an effective treatment that is also financially accessible to patients. However, itÔÇÖs important to note that there are specific eligibility criteria for patients seeking to benefit from this funding.

Merlin Kalle, a board member of the Estonian migraine and headache patients association, has also praised the funding of the new migraine drug as a positive step. While acknowledging the importance of this development, Kalle highlighted the need for the drug to become more accessible to a larger number of people, ensuring that those who can benefit from it are able to do so.

Furthermore, in the new year, the Health Insurance Fund will cover the costs of several new hospital and prescription drugs, expanding treatment options for a range of conditions, including migraine, multiple sclerosis, thrombocytopenia, asthma, atopic dermatitis, non-Hodgkin’s lymphoma, congestive heart failure, chronic kidney disease, growth hormone deficiency, nasopharyngitis with polyps, and several cancers.

How AI legalese decoder Can Help:
AI legalese decoder can assist in making this complex process more accessible and understandable for patients and healthcare providers. By simplifying the legal jargon related to funding and eligibility criteria, the AI tool can help patients understand their rights and access to the newly funded treatments. Additionally, healthcare professionals can use AI legalese decoder to swiftly understand and communicate the intricate details of the funding process, ensuring that the right patients receive the much-needed treatment for chronic migraine and other conditions.

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link